Ablynx NV (XBRU:ABLXS) Days Sales Outstanding : 27.26 (As of Dec. 2017)

View and export this data going back to . Start your Free Trial

What is Ablynx NV Days Sales Outstanding?

Ablynx NV's average Accounts Receivable for the six months ended in Dec. 2017 was €3.12 Mil. Ablynx NV's Revenue for the six months ended in Dec. 2017 was €20.90 Mil. Hence, Ablynx NV's Days Sales Outstanding for the six months ended in Dec. 2017 was 27.26.

The historical rank and industry rank for Ablynx NV's Days Sales Outstanding or its related term are showing as below:

XBRU:ABLXS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.99 Med: 20.87 Max: 90.78
Current: 13.87

During the past 12 years, Ablynx NV's highest Days Sales Outstanding was 90.78. The lowest was 2.99. And the median was 20.87.

XBRU:ABLXS's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.665 vs XBRU:ABLXS: 13.87

Ablynx NV's Days Sales Outstanding increased from Dec. 2016 (13.57) to Dec. 2017 (27.26).

Ablynx NV Days Sales Outstanding Historical Data

The historical data trend for Ablynx NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Days Sales Outstanding Chart

Ablynx NV Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Days Sales Outstanding

Get a 7-Day Free Trial

3.52

2.08

32.25

22.16

18.47

Ablynx NV Semi-Annual Data
	Dec07	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17
Days Sales Outstanding	Get a 7-Day Free Trial															27.37	13.70	13.57	20.12	27.26

Competitive Comparison of Ablynx NV's Days Sales Outstanding

For the Biotechnology subindustry, Ablynx NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ablynx NV's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Days Sales Outstanding falls into.

Ablynx NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ablynx NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2017 is calculated as

	Days Sales Outstanding (A: Dec. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2016 )	+	Accounts Receivable (A: Dec. 2017 ))	/	count )	/	Revenue (A: Dec. 2017 )	*	Days in Period
=	( (3.512	+	2.111)	/	2 )	/	55.562	*	365
=	2.8115					/	55.562	*	365
=	18.47

Ablynx NV's Days Sales Outstanding for the quarter that ended in Dec. 2017 is calculated as:

	Days Sales Outstanding (Q: Dec. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2017 )	+	Accounts Receivable (A: Dec. 2017 ))	/	count )	/	Revenue (A: Dec. 2017 )	*	Days in Period
=	( (4.132	+	2.111)	/	2 )	/	20.897	*	365 / 2
=	3.1215					/	20.897	*	365 / 2
=	27.26

Ablynx NV (XBRU:ABLXS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ablynx NV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ablynx NV (XBRU:ABLXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.ablynx.com

Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines